secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clene Inc. (CLNN)
CIK:        0001822791
Form:       8-K
Filed at:   2023-09-19T23:59:59+00:00
Accession:  0001437749-23-026257
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Clene appoints Prof. Kiernan and Dr. Desai to Board; Dr. Stevens retires
------------------------------------------------------------------------

- Appointed Prof. Matthew Kiernan (neurology chair, University of Sydney) and Dr. Arjun Desai (INSIGHTEC exec) as Class II directors.
- Each received 45,000 common stock options at $0.54 exercise price, vesting monthly over 36 months.
- Director John H. Stevens retired immediately, not due to any disagreement; he served since 2015.
- Jonathon T. Gay joined Audit Committee; Dr. Desai joined Compensation Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/0001437749-23-026257-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822791/000143774923026257/clnn20230914_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-026257

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer